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Abstract Objective: To evaluate the
impact of helium-oxygen (He/O2) on
inspiratory effort and work of
breathing (WOB) in intubated COPD
patients ventilated with pressure
support. Design and setting:
Prospective crossover interventional
study in the medical ICU of a uni-
versity hospital. Patients and partic-
ipants: Ten patients. Interventions:
Sequential inhalation (30 min each)
of three gas mixtures: (a) air/O2, (b)
He/O2 (c) air/O2, at constant FIO2
and level of pressure support. Mea-
surements and results: Inspiratory
effort and WOB were determined by
esophageal and gastric pressure.
Throughout the study pressure sup-
port and FIO2 were 14€3 cmH2O and
0.33€0.07 respectively. Compared to
Air/O2, He/O2 reduced the number of
ineffective breaths (4€5 vs. 9€5
breaths/min), intrinsic PEEP (3.1€2
vs. 4.8€2 cmH2O), the magnitude
of negative esophageal pressure
swings (6.7€2 vs. 9.1€4.9 cmH2O),
pressure-time product (42€37 vs.
67€65 cmH2O s
1 min1), and total
WOB (11€3 vs. 18€10 J/min). Elastic
(6€1 vs. 10€6 J/min) and resistive
(5€1 vs. 9€4 J/min) components of
the WOB were decreased by He/O2.
Conclusions: In intubated COPD pa-
tients ventilated with pressure sup-
port He/O2 reduces intrinsic PEEP,
the number of ineffective breaths, and
the magnitude of inspiratory effort
and WOB. He/O2 could prove useful
in patients with high levels of PEEPi
and WOB ventilated in pressure
support, for example, during wean-
ing.
Keywords Helium · Heliox ·
Pressure support · Mechanical
ventilation · Work of breathing
Introduction
In decompensated chronic obstructive pulmonary disease
(COPD) there is a marked increase in both the elastic and
resistive components of the work of breathing (WOB) [1,
2, 3]. The ensuing respiratory muscle fatigue is a key
factor determining weaning trial failure [4, 5], and pro-
longed ventilator dependence [1] in intubated patients.
Pressure support (PS) is often used to provide a titrable
level of respiratory muscle unloading in these patients [1].
However, excessive levels of PS can adversely affect
patient-ventilator synchrony and increase WOB [6, 7].
Likewise, applying external positive end-expiratory
pressure (PEEPe) can offset the inspiratory threshold ef-
fect of intrinsic PEEP (PEEPi) [8], but PEEPe may be
difficult to titrate and can increase total PEEP and dy-
namic hyperinflation [9, 10]. On the other hand, helium-
oxygen (He/O2) reduces the resistance to flow within the
airways due to its low density [11]. In turn this effect has
been shown to enhance lung emptying and decrease
PEEPi [12] and to reduce WOB during controlled me-
chanical ventilation [13] and T-piece breathing [14] in
intubated COPD. However, while two studies have shown
that He/O2 can exert such beneficial effects in acutely
decompensated COPD patients undergoing noninvasive
PS [15, 16], no study has so far addressed whether these
beneficial effects could also be observed in intubated
patients. Such a favorable impact might indeed improve
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patient tolerance and endurance to spontaneous-assisted
ventilation, for example, during weaning, while avoiding
the deleterious effects of excessive respiratory muscle
loading [17]. The purpose of the present study was
therefore to test the hypothesis that He/O2 can reduce
PEEPi and the magnitude of inspiratory effort and WOB
during PS in intubated COPD patients.
Results from this study were presented in abstract form
at the 2005 annual meeting of the American Thoracic
Society [18].
Patients and methods
Patients
Patients were consecutively included if they met the commonly
accepted criteria for COPD [19], were intubated, and in PS mode.
Exclusion criteria were the presence of pneumothorax and/or
hypoxemia requiring an inspired O2 fraction (FIO2) of 0.45 or
higher. Ten patients were consecutively included in the study; pa-
tients’ main clinical characteristics are summarized in Table 1.
Data collection was complete in all patients. As seen in their most
recent FEV 1.0 values from the 2 years prior to admission, patients
had severe obstructive disease. The protocol was accepted by the
Ethics committee of our institution. Informed consent was obtained
from all patients.
Methods
Prior to protocol initiation a nasogastric tube with esophageal and
gastric balloons (Guenard ch 16 nasogastric tube, Marquat Gnie
Biomdical, Boissy-Saint-Lger, France) was inserted, and its
correct position verified by the occlusion method [20]. The elec-
tromyographic activity of the diaphragm (EMGd) was recorded
with two surface electrodes positioned on the right and left costal
margins with a reference electrode placed over the sternum [21].
After filtering and digitalization at a sampling rate of 1000 Hz by
means of the Biopac EMG module (Biopac Systems, Goleta, Calif.,
USA) the EMGd signal was rectified and integrated [22].
Patients were placed in a semirecumbent position, and the
protocol was initiated after tracheal suctioning. All patients were
ventilated with a Galileo Gold Series ventilator (Hamilton Medical,
Rhzuns, Switzerland), which can be safely used to deliver He/O2
without any modifications [23]. He/O2 was administered as previ-
ously described [12, 16]. Briefly, a 50-l canister pressurized at
200 bar (Carbagas, Gmligen, Switzerland) containing a 78:22
mixture of He and O2 was connected through a pressure regulator at
6 bar into the ventilator’s air inlet. A correction factor for reported
tidal volume (VT) was used, since the VT reading on the ventilator
underestimates the actual VT during He/O2 use [23]. The VT
computed with this correction factor was also checked against true
VT measured with a precision density-independent spirometer
(5420 Volume Monitor, Ohmeda, Louisville, Col., USA). A heat
and moisture exchanger was fitted on the ventilator circuit between
the endotracheal tube and the Y-piece in all patients-PS was set by
the clinician in charge of the patient, following our usual practice
guidelines, i.e., FIO2 adjusted to maintain SpO2 at a level higher
than 0.9, level of PS titrated to obtain an expired VT of 8 ml/kg,
pressurization time of 0.2 s, inspiratory trigger set at maximum
sensitivity, and inspiratory:expiratory cycling set at 25% of peak
inspiratory flow rate. PEEPa to compensate for the inspiratory
threshold load of PEEPi was added following our usual protocol,
i.e., starting at zero end-expiratory pressure and increasing by
1 cmH2O increments until ineffective inspiratory attempts disap-
peared or decreased [8] to a maximum of 10 cmH2O.
After an initial 30 min period with Air/O2 patients were swit-
ched to the He/O2 mixture for 30 min, then back again for 30 min to
Air/O2. All ventilator settings including FIO2 were kept constant
throughout the protocol. Heart rate, arterial blood pressure, and
pulse oxymetry were continuously monitored.
Measurement protocol
Data recordings were performed during the last 5 min of ventilation
with each gas mixture. Esophageal (Pes) and gastric pressures (Pga)
were continuously recorded by differential pressure transducers
(Biopac), all signals being digitalized at a sampling rate of
1000 Hz, and stored in a laptop computer for subsequent analysis
(AcqKnowledge software, Biopac). Patient inspiratory effort time
(ti) was measured as the interval between the initial decrease in Pes
and the initial rapid decrease of electrical activity on the processed
EMGd signal [22, 24].
The following parameters were determined during each phase of
the protocol: VT, minute-volume (V0E), and peak expiratory flow
(V0exp) obtained by analysis of the instantaneous flow tracing; peak
expiratory resistance (Rexp) computed as Rexp=PawPes/V0exp,
where Paw=airway pressure; the expiratory time constant (te), de-
Table 1 Main clinical characteristics and initial ventilator settings
(BW body weight, FEV1.0 last documented value of 1-s forced
expiratory volume in absolute value and percentage of predicted
value, FIO2 inspired O2 fraction, PS level of pressure support above
PEEPe, PEEPe level of externally applied positive end-expiratory
pressure)
Patient no. Age (years) Sex BW (kg) FIO2 FEV1.0 (l; % pred PS (cmH2O) PEEPe (cmH2O)
1 77 M 55 0.25 0.60 (20) 11 7
2 57 M 65 0.25 – 14 7
3 65 M 47 0.30 – 12 10
4 77 M 60 0.40 0.76 (19) 13 6
5 78 M 67 0.25 – 14 5
6 71 M 60 0.40 1.12 (42) 12 5
7 77 F 56 0.40 0.44 (26) 15 10
8 75 F 57 0.40 0.68 (32) 12 5
9 60 M 68 0.35 0.57 (20) 18 8
10 50 F 50 0.35 – 22 10
mean 68.7 58.5 0.33 0.69/26 14.3 7.3
(SD) (10.1) (6.9) (0.07) (0.23)/(9) (3.4) (2.1)
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termined by analysis of the expiratory flow-volume tracing [25];
respiratory rate reported by the ventilator (RRvent); patient respi-
ratory rate (RRpat) determined from EMGd and Pes tracings;
number of ineffective inspiratory attempts (Rineff), computed as
Rineff=RRpatRRvent; PEEPi: the Pes difference between the onset of
inspiratory effort and the point at which instantaneous expiratory
flow reached 0, further corrected for any expiratory muscle activity
[26]; trigger delay (Td): the time difference between the onset of
inspiratory effort and that of pressurization by the ventilator; du-
ration of delayed cycling (tiexcess), computed as the difference be-
tween the end of ti and the duration of pressurization by the ven-
tilator. Respiratory muscle workload can be determined by two
approaches. One is to compute it from the esophageal pressure and
flow tracings. Its drawback is that it is dependent on flow, and
therefore does not take into account the ineffective inspiratory ef-
forts which are often present in COPD. Hence this technique un-
derestimates the magnitude of inspiratory muscle workload. How-
ever, its main advantage is that it allows determination of total
transpulmonary WOB and its partition into elastic and resistive
components, which is important to assess the various effects of
helium in obstructive patients. The other approach is to compute the
pressure-time product, which does not depend on flow, and there-
fore takes into account the workload imposed by ineffective in-
spiratory attempts. This technique is also well correlated with
respiratory muscle oxygen consumption and therefore with the
metabolic cost of breathing. We therefore used both methods in the
present study. Inspiratory WOB was determined by analysis of the
PesVT tracing, using the classical method based on the Campbell
diagram [15, 27]: briefly, WOB was determined as the area en-
closed between (a) the inspiratory PesVT curve and (b) the static
esophageal chest wall pressure-volume curve, using a theoretical
chest wall compliance value (4% of the predicted value of the vital
capacity/cmH2O). WOB was expressed as work per breath (J/cycle)
and per volume unit (J/l).
Using measurements of transpulmonary pressure (i.e., the dif-
ference between airway pressure, Paw, measured at the endotra-
cheal tube, and Pes), total transpulmonary work per minute (Wtptot,
J/min) was determined, and partitioned into its resistive (Wtpres, J/
min) and elastic (Wtpel, J/min) components [15]. Finally, due to the
presence of ineffective inspiratory attempts inspiratory effort was
also quantified by computation of transdiaphragmatic pressure
(Pdi), as well as total (PTPdi) and triggering (PTPt) pressure-time
products, which are independent of flow and volume signals [28].
WOB was thus computed only for those patient breaths which
triggered the ventilator, as was the PTPt, while Pdi and PTPdi were
determined for both triggering and nontriggering breaths. Arterial
blood gases were analyzed at the end of each study phase. Figure 1
illustrates the various time intervals from a patient.
Statistics
Data are expressed as mean €standard deviation. Comparisons
(SigmaStat 2.0, SPSS Science) between the three conditions was
made by analysis of variance, significance between the time points
being determined by Fisher’s protected least significance test. A p
value less than 0.05 was considered significant.
Fig. 1 Representative tracing
from a patient, illustrating the
various time intervals used.
Paw Airway pressure; Flow in-
stantaneous flow measured at
airway opening; Pdi transdi-
aphragmatic pressure; EMGd
electromyographic recording of
the diaphragm; td trigger delay;
ti patient inspiratory effort du-
ration; tiassist duration of pres-
surization by the ventilator;
tiexcess duration of pressuriza-
tion by the ventilator extending
beyond the end of ti
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Results
No significant differences were observed between the Air/
O2 1 and Air/O2 2 data sets. The patients’ respiratory
pattern for each condition are shown in Table 2. Expira-
tory resistance, expiratory time constant, and peak expi-
ratory flow all decreased with He/O2. PEEPi was present
in all patients, and its magnitude was decreased by He/O2
as well as the number of ineffective inspiratory attempts.
Delayed cycling (tiexcess) was present in all patients but
was not influenced by He/O2. Table 3 summarizes the
main findings with respect to inspiratory effort and WOB.
The magnitude of inspiratory effort, characterized by the
Pes and Pdi variations, was decreased by He/O2, as was the
PTP. The individual variations or Pdi swings are shown in
Fig. 2. The total WOB determined from the Pes tracing
was reduced during He/O2 inhalation. Finally, WOB
computed from the transpulmonary pressure measure-
ments was also decreased by He/O2, in both its elastic and
its resistive components. As shown in Table 4, He/O2 had
no effect on arterial blood gases or hemodynamics.
Discussion
The findings of the present study demonstrate that in in-
tubated patients with severe COPD ventilated in PS He/
O2 decreases the level of PEEPi and the number of in-
effective inspiratory attempts and also reduces the mag-
nitude of inspiratory efforts and the total WOB as well as
its resistive and elastic components. Let us now attempt to
put these results in perspective and assess how they may
affect the weaning process in COPD patients.
Several limitations of the study should be noted ini-
tially. First, only a small number of patients was studied.
However, all patients exhibited the same response pattern
when switched from one gas mixture to another. Second,
the static esophageal chest wall pressure-volume curve
was determined using a theoretical chest wall compliance
Table 2 Patients’ respiratory pattern and mechanics [IEineff inef-
fective inspiratory efforts (IEineff=RRpatRRvent), PEEPi intrinsic
positive end-expiratory pressure, Rexp peak expiratory resistance
computed as Rexp=(airwayesophageal pressure)/peak expiratory
flow, RRpat patient respiratory rate, RRvent respiratory rate reported
by the ventilator, VT tidal volume, VE minute ventilation, ti dura-
tion of patient inspiratory effort, V0exp peak expiratory flow, te
expiratory time constant, tiexcess duration of pressurization by the
ventilator extending beyond the end of ti, td trigger delay (time
between onset of ti and onset of pressurization by the ventilator)]
Air/O2 1 He/O2 Air/O2 2
RRvent (b/min) 16€3.6 13.1€3.1* 16.2€3.9
RRpat (b/min) 23.6€6.1 19.2€5.4* 23€5.2
IEineff (b/min) 9€5 4€5* 6.2€4
VT (l) 0.601€0.228 0.621€0.276 0.611€0.258
VE (l/min) 9.04€2.8 8.25€5.3 9.40€3.5
ti (s) 0.688€0.23 0.704€0.23 0.728€0.254
td (s) 0.489€0.241 0.472€0.229 0.511€0.243
ti excess (s) 0.899€0.36 0.876€0.384 0.873€0.377
PEEPi (cmH2O) 4.8€2.7 3.1€2.7* 5€2.6
V0exp (l/s) 0.63€0.18 0.89€0.66* 0.62€0.18
te(s) 2.06€0.93 1.42€0.88** 2.06€0.94
Rexp (cmH2O l
1s1) 29.7€11 22.5€9* 29.6€10
* p<0.05 vs. AirO2 1 and AirO2 2, ** p<0.01 vs. AirO2 1 and AirO2 2 (analysis of variance)
Table 3 Patients’ inspiratory effort and work of breathing [DPeso
magnitude of esophageal pressure swings, DPdi magnitude of
transdiaphragmatic pressure swings, PTPeso esophageal pressure-
time product expressed per cycle and time unit, PTPt triggering
pressure-time product per cycle, Weso work of breathing derived
from esophageal pressure tracing expressed per cycle and time unit,
Wtp total (tot), resistive (res), and elastic (el) work of breathing
derived from transpulmonary pressure measurements)
Air/O2 1 He/O2 Air/O2 2
DPeso (cmH2O) 9.1€4.9 6.7€2* 8.9€5
DPdi (cmH2O) 6.8€5.9 5.7€2.5* 6.7€5.1
PTPeso/cycle (cmH2O/s) 4.1€3.6 2.5€2.4* 4.3€3.9
PTPeso/min (cmH2O s
1 min1) 67.1€65 41.8€37.4* 69.7€66.1
PTPt/cycle (cmH2O/s) 2.2€1.5 1.5€0.8* 2.1€1.7
Weso/cycles (J/cycle) 0.253€0.30 0.105€0.098* 0.260€0.3
Weso/min (J/min) 4.2€5.8 1.7€1.5* 4.2€5.8
Wtptot (J/min) 18.2€10.7 10.7€3.5* 18.2€10.6
Wtpres (J/min) 8.51€4.4 4.9€1.1* 8.46€4.3
Wtpel (J/min) 10.3€6.5 6.1€1.3* 10.2€6.5
* p<0.05 vs. AirO2 1 and AirO2 2 (analysis of variance)
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rather than a measured value. Nonetheless, although some
degree of error can occur with this approach, comparisons
between those conditions remains valid, given that the
error is present in all measurement conditions [27]. Third,
He/O2 was administered for 30 min, which might be in-
sufficient for its full effects to occur in very inhomoge-
neous lungs such as those of COPD. However, this du-
ration is in line with that of other studies in which a highly
significant effect of He/O2 was documented after 20–
45 min [10, 12, 13, 14, 15, 16]. Fourth, during sponta-
neous-assisted breathing reliable measurements of static
respiratory system compliance are not possible, leading to
some difficulties in interpreting changes in the elastic
component of the WOB (Wtpel) [13].
Overall our findings are in line with those of recent
studies on He/O2 in intubated COPD patients. During
controlled ventilation a decrease in dynamic hyperinfla-
tion and PEEPi with He/O2 has been shown [10, 12]. The
level of PEEPi was lower in the present study, which is to
be expected as patients were in the weaning phase,
whereas those of the two former studies had been intu-
bated for less than 48 h. However, the magnitude of de-
crease in PEEPi was comparable between these three
studies. Recently Gainnier et al. [13] obtained similar
results in patients undergoing controlled ventilation and
also documented a reduction in total, resistive, and elastic
WOB with He/O2. The magnitude of decrease in total and
individual determinants of WOB was greater in our pa-
tients, although the ventilatory mode and timing with
regards to intubation were different. This discrepancy
probably results from the different measurement tech-
niques used as well as from the fact that their patients
were in controlled conditions while those of the present
study were undergoing PSV.
In spontaneously breathing COPD patients immedi-
ately before extubation without any ventilatory assistance
Diehl et al. [14] also observed that He/O2 reduced the
level of PEEPi and the WOB, mainly of its resistive
component. PEEPi was lower than that in our patients,
which is to be expected given that the Diehl et al. study
was performed immediately before extubation. Likewise,
and probably for the same reasons, the reduction in WOB
was smaller in the patients studied by Diehl et al. Finally,
during noninvasive PSV applied by face mask to acutely
decompensated patients He/O2 leads to a reduction in
WOB [15], PaCO2, and dyspnea [15, 16]. Jaber et al. [15]
found that PSV at levels comparable to that in our patients
decreased the intensity of inspiratory efforts and WOB.
The magnitude of these changes was close to that ob-
served in our patients, although PSV was applied nonin-
vasively and to acutely decompensated patients.
The effects of He/O2 on the patients’ ventilatory pat-
tern should be briefly discussed. First, one might have
expected the triggering delay to decrease while breathing
He/O2, as PEEPi, which represents an inspiratory
threshold load, was reduced. The fact that only a non-
significant trend towards a lower delay was documented
probably stems from the low initial level of PEEPi in our
patients. Delayed cycling was unaffected by He/O2. This
is not surprising given that delayed cycling is influenced
by several factors such as the cycling cutoff level of the
ventilator (25% of peak inspiratory flow in this study), the
time constant of the respiratory system (RC), duration and
magnitude of inspiratory effort, level of PS, and profile of
the pressure-time curve [22, 29]. Quantitatively the most
important determinant of delayed cycling is the ratio be-
tween RC and inspiratory time [22, 29]. While elastance
and resistance were not measured, the decrease in elastic
Fig. 2 Individual variations in transdiaphragmatic pressure swings
during the three phases of the study
Table 4 Arterial blood gases and hemodynamics; all differences
nonsignificant (HR heart rate, MAP mean arterial pressure, PaO2
arterial partial pressure of O2, PaCO2 arterial partial pressure of
CO2, SaO2 O2 saturation of arterial blood)
Air/O2 1 He/O2 Air/O2 2
pH 7.39€0.09 7.37€0.05 7.38€0.07
PaCO2 (torr) 51€4 52€2 52€3
PaO2 (torr) 71€5 74€3 74€4
SaO2 (%) 98€0.9 98€1.7 98€0.6
HR (n/min) 83€19 82€17 83€18
MAP (mmHg) 85€13 86€12 87€12
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and resistive components of the WOB suggests that both
determinants of the RC were reduced, and therefore that
RC remained unchanged. Inspiratory time was also un-
changed. Therefore no modification in the magnitude of
delayed cycling was observed, as one would expect.
Of note, no effect of He/O2 on PaCO2 was observed.
However, the key factor determining the impact of heliox
on PaCO2 is probably its initial level. In a previous study
in patients undergoing noninvasive PS we found that
PaCO2 was lowered the most in those patients who had
the highest initial levels of hypercapnia [16], a finding
which has subsequently been confirmed by Jaber et al.
[15]. In the present study the patients were not acutely
decompensated or severely hypercapnic but represented a
heterogeneous group of patients who had been intubated,
ventilated in controlled mode, and at various stages of the
weaning process in PS. Therefore some patients were
nonhypercapnic while others had no elevation or only
moderate increases in PaCO2. Illustrating this point, we
found no effect on PaCO2 in patients without marked
hypercapnia in two studies in intubated patients under-
going controlled ventilation [10, 12].
Our results confirm that He/O2, by reducing expiratory
airways resistance, can increase expiratory flow, thereby
leading to enhanced lung emptying and a decrease in
PEEPi. This in turn leads to several beneficial effects.
First, the decreased inspiratory threshold load induces a
reduction in the number of nontriggering breaths and most
likely accounts for the decrease in the magnitudes of
esophageal pressure swings and PTP. Second, through the
reduction in PEEPi and airways resistance there is a de-
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can interfere with ventilator function, thus requiring
thorough knowledge of these technical aspects by inten-
sivists to ensure patient safety [23]. Finally, cost can be an
issue, although probably not a major one [30].
In conclusion, the present study demonstrates that in
intubated COPD patients ventilated with PS He/O2 en-
hances lung emptying, decreases PEEPi and the number
of ineffective inspiratory attempts, and reduces the vari-
ous key determinants of elevated WOB and inspiratory
effort. He/O2 may therefore prove useful in patients with
high levels of PEEPi and WOB by unloading the respi-
ratory muscles. This can improve patient-ventilator in-
teraction and tolerance to spontaneous-assisted breathing,
which in turn may be beneficial for patient outcome, for
example, by facilitating weaning. However, the optimal
timing and duration of He/O2 administration remains to
be determined. Furthermore, given the technical pitfalls
and cost issues associated with the use of He/O2, studies
are needed to determine whether the beneficial patho-
physiologocal effects of He/O2 inhalation during weaning
can have an impact on the duration of weaning, ICU stay,
and overall patient outcome.
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